Pricing

Log inSign up
  • ReCode Therapeutics

Research and Development

About

The Research and Development team at ReCode Therapeutics focuses on advancing targeted, disease-modifying therapies for life-limiting respiratory diseases. This diverse group of scientists and researchers works on various aspects of drug discovery and development, including gene editing, in vivo and in vitro pharmacology, formulation, process development, and bioanalytical assay development, to bring innovative genetic medicines from concept to clinical application.


People (20)

Alanna Manning

Associate Engineer II

Ali Alfaifi

Senior Scientist - Formulation Discovery and Delivery

Carrolee Barlow

Scientific Advisor

DS

Daniel J. Siegwart

Chair, Scientific Advisory Board

Elliott Sigal

Scientific Advisor

Eric Olson

Scientific Advisor

Issamar Salazar

Research Associate

Joe Cefalu

Senior Director of In Vivo Pharmacology

Joseph Chen

Director, Translational Sciences

Jung-un Julia Baek

Senior Scientist II

Justin Hanes

Scientific Advisor

Malak El-Khatib

Scientist II

Marcus Jellen

Scientist II

Min Chen

Senior Scientist I

Neda Mahmoudi

Senior Scientist II

Rafael Amado

Scientific Advisor

SK

Sahitya Katikaneni

Senior Scientist II - CMC Formulation

SM

Sakya Mohapatra

Senior Director, Formulation and Process Development

Samuel Chung

Senior Scientist Ii, Lung Biology

Wiputra Hartono

Scientist II - Gene Editing


Jobs (0)

No jobs in this team


Other teams

Directors Team

12 people · 0 jobs

Leadership Team

3 people · 0 jobs

Business Development & Strategy

3 people · 0 jobs

Company
AboutContactBlog
Business
SolutionsTrustPricing
Directory
CompaniesPeople
Enrich
Browser ExtensionCRM EnrichmentDeveloper Portal
Social
© 2026 Orgio, Inc.
Terms
Privacy
Do not sell my info